Close Menu

NEW YORK — AnPac Bio-Medical Science said on Thursday that it has priced its initial public offering of roughly 1.3 million American depositary shares (ADS) at $12 apiece, for total proceeds of around $16.0 million.

Each ADS represents one Class A ordinary share of AnPac.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.